SPION nanoparticles for delivery of dopaminergic isoquinoline and benzazepine derivatives
- 27 June 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 69, 116910
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- 2,3,9- and 2,3,11-Trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligandsEuropean Journal of Medicinal Chemistry, 2013
- Nanomaterials for (Nano)medicineACS Medicinal Chemistry Letters, 2012
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2012
- Hybrid microparticles for drug delivery and magnetic resonance imagingJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2012
- Nanoparticles enhance brain delivery of blood–brain barrier-impermeable probes for in vivo optical and magnetic resonance imagingProceedings of the National Academy of Sciences, 2011
- Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brainProceedings of the National Academy of Sciences, 2010
- Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization StrategiesDiscover Nano, 2008
- On the brainNature Nanotechnology, 2007
- Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric DisordersChemical Reviews, 2006
- The palladium(0) Suzuki cross-coupling reaction as the key step in the synthesis of aporphinoidsTetrahedron, 2004